Preparedness New Funding Expands U.S. Special Pathogen Preparedness Through STAND ProgramGlobal Biodefense StaffOctober 12, 2025
Infectious Diseases Mpox Resurgence: A Global Wake-Up Call for Zoonotic Disease PreparednessGlobal Biodefense StaffSeptember 4, 2025
Preparedness Drug Shortages, Public Health Preparedness, and the Contradictions of U.S. PolicyGlobal Biodefense StaffSeptember 3, 2025
Preparing for Bioterrorism: Sloan’s Impact on Biosecurity and Biodefense Biosecurity December 13, 2012 …
Novartis Receives FDA Approval for First Cell-Culture Influenza Vaccine Industry News November 23, 2012 …
Emergent Biosolutions, Novartis, Texas A&M to Lead New Biodefense Centers Contracts + Grants June 19, 2012 …
